IntelGenx Technologies Corp.

Common Stock SEC Reporting - Current
Verified Company Profile 1/27/2017
Contact Info
  • 6420 Abrams
  • St. Laurent, QC H4S 1Y2
  • Canada

Business Description

Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Dec 31, 2016 10-K
CIK 0001098880
Fiscal Year End 12/31
OTC Marketplace OTCQX U.S.
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: DE, USA
Year of Inc. 2003
Employees 26 a/o Mar 01, 2016
Company Officers/Contacts
Horst G. Zerbe, Ph.D CEO, President
Ingrid Zerbe Corporate Secretary
Karen Kalajajian Controller
Edward Miller IR
Company Directors
Horst G. Zerbe, Ph.D Chairman
J. Bernard Boudreau Independent Director, Compensation Committee Member, Nominating Committee Member
Service Providers
Accounting/Auditing Firm
Richter LLC.
1981 McGill College
Montreal, QC, H3A 0G6
Securities Counsel
Dorsey & Whitney LLP
TD Canada Trust Tower Brookfield Place
161 Bay Street
Suite 4310
Toronto, ONT, M5J 2S1
Investor Relations Firm

Not Available
Company History
  • Sponsored for OTCQX by Dorsey & Whitney LLP on 06/14/2012
IGXT Security Details
Share Structure
Market Value1 $51,096,897 a/o Mar 28, 2017
Authorized Shares 100,000,000 a/o Jan 26, 2017
Outstanding Shares 65,237,021 a/o Jan 26, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 54,797,920 a/o Jan 26, 2017
Par Value 0.00001
Shareholders of Record 46 a/o Jan 26, 2017
Short Selling Data
Short Interest 86,819 (745.45%)
Feb 15, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security